SC 13D Filing

Company

PUMA BIOTECHNOLOGY, INC.

Filed

November 21, 2007

Accession Number

0001144204-07-063805

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →